Veronika Heil, based in Boston, MA, US, is currently a Associate Scientist at Arkuda Therapeutics, bringing experience from previous roles at Vesalius Therapeutics, AbbVie and Harvard Medical School. Veronika Heil holds a 2017 - 2020 Master of Science - MS in Neuroscience @ Heidelberg University.